The year in cardiovascular medicine 2020: valvular heart disease (2025)

  • Record: found
  • Abstract: found
  • Article: found

Is Open Access

research-article

The year in cardiovascular medicine 2020: valvular heart disease (1)

Author(s):

Javier Bermejo ehaa1060-aff1 ,

Andrea Postigo ehaa1060-aff1 ,

Helmut Baumgartner ehaa1060-aff2

Publication date (Electronic): 03 January 2021

Journal: European Heart Journal

Publisher: Oxford University Press

Keywords: Valvular heart disease

Read this article at

ScienceOpenPublisherPMC

  • Download PDF
  • XML
  • Review article
  • Invite someone to review

Bookmark

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Graphical Abstract

      The year in cardiovascular medicine 2020: valvular heart disease (2)

      Proposed framework for classifying coexisting mitral regurgitation and severe LV systolic dysfunction. This framework is based on ancillary analyses of randomized clinical trials and prospective validation is pending. ERO: effective regurgitant orifice. EDV: end-diastolic volume. TMVr: transcatheter mitral valve repair.

      Related collections

      Most cited references74

      • Record: found
      • Abstract: found
      • Article: not found

      Burden of Tricuspid Regurgitation inPatients Diagnosed in the CommunitySetting

      Yan Topilsky, Simon Maltais, Jose R. Medina Inojosa (2018)

      This study sought to analyze patients with tricuspid regurgitation (TR) diagnosed in the community setting (Olmsted County) by Doppler echocardiography to define the prevalence, characteristics, and implications of clinically significant (greater or equal to moderate) TR.

      0 comments Cited 212 times – based on 0 reviews Review now

        Bookmark

        • Record: found
        • Abstract: found
        • Article: not found

        Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

        Raj R Makkar, Vinod H Thourani, Michael J Mack (2020)

        There are scant data on long-term clinical outcomes and bioprosthetic-valve function after transcatheter aortic-valve replacement (TAVR) as compared with surgical aortic-valve replacement in patients with severe aortic stenosis and intermediate surgical risk.

        0 comments Cited 200 times – based on 0 reviews Review now

          Bookmark

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

          Gilbert Habib, Paola Anna Erba, Bernard Iung (2019)

          The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE). Prospective cohort of 3116 adult patients (2470 from Europe, 646 from non-ESC countries), admitted to 156 hospitals in 40 countries between January 2016 and March 2018 with a diagnosis of IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, and imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)] data were collected. Infective endocarditis was native (NVE) in 1764 (56.6%) patients, prosthetic (PVIE) in 939 (30.1%), and device-related (CDRIE) in 308 (9.9%). Infective endocarditis was community-acquired in 2046 (65.66%) patients. Microorganisms involved were staphylococci in 1085 (44.1%) patients, oral streptococci in 304 (12.3%), enterococci in 390 (15.8%), and Streptococcus gallolyticus in 162 (6.6%). 18F-fluorodeoxyglucose positron emission tomography/computed tomography was performed in 518 (16.6%) patients and presented with cardiac uptake (major criterion) in 222 (42.9%) patients, with a better sensitivity in PVIE (66.8%) than in NVE (28.0%) and CDRIE (16.3%). Embolic events occurred in 20.6% of patients, and were significantly associated with tricuspid or pulmonary IE, presence of a vegetation and Staphylococcus aureus IE. According to ESC guidelines, cardiac surgery was indicated in 2160 (69.3%) patients, but finally performed in only 1596 (73.9%) of them. In-hospital death occurred in 532 (17.1%) patients and was more frequent in PVIE. Independent predictors of mortality were Charlson index, creatinine > 2 mg/dL, congestive heart failure, vegetation length > 10 mm, cerebral complications, abscess, and failure to undertake surgery when indicated. Infective endocarditis is still a life-threatening disease with frequent lethal outcome despite profound changes in its clinical, microbiological, imaging, and therapeutic profiles.

          0 comments Cited 189 times – based on 0 reviews Review now

            Bookmark

            All references

            Author and article information

            Journal

            Journal ID (nlm-ta): Eur Heart J

            Journal ID (iso-abbrev): Eur Heart J

            Journal ID (publisher-id): eurheartj

            Title: European Heart Journal

            Publisher: Oxford University Press

            ISSN (Print): 0195-668X

            ISSN (Electronic): 1522-9645

            Publication date Collection: 07 February 2021

            Publication date (Electronic): 03 January 2021

            Publication date PMC-release: 03 January 2021

            Volume: 42

            Issue: 6 , Focus Issue on Heart Failure and Cardiomyopathies

            Pages: 647-656

            Affiliations

            [ehaa1060-aff1 ] Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid and CIBERCV , Dr Esquerdo 46, Madrid 28007, Spain

            [ehaa1060-aff2 ] Department of Cardiology III—Adult Congenital and Valvular Heart Disease, University Hospital Muenster , Albert-Schweitzer-Campus 1, 48149 Münster, Germany

            Author notes

            Corresponding author. Tel: +34 91 5868279, Fax: +34 91 5866727, Email: javier.bermejo@ 123456salud.madrid.org

            Author information
            Article

            Publisher ID: ehaa1060

            DOI: 10.1093/eurheartj/ehaa1060

            PMC ID: 7878012

            PubMed ID: 33388778

            SO-VID: 3e44a322-b5b3-452b-a7fe-895cc6b8c4f0

            Copyright © © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

            License:

            This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

            History

            Date received : 30 September 2020

            Date revision received : 11 November 2020

            Date accepted : 16 December 2020

            Date: 10 December 2020

            Page count

            Pages: 10

            Categories

            Subject: Special Articles

            Subject: Editor's Choice

            Subject: AcademicSubjects/MED00200


            ScienceOpen disciplines: Cardiovascular Medicine

            Keywords: valvular heart disease

            Data availability:

            ScienceOpen disciplines: Cardiovascular Medicine

            Keywords: valvular heart disease

            Comments

            Comment on this article

            Sign in to comment

            The year in cardiovascular medicine 2020: valvular heart disease (2025)
            Top Articles
            Latest Posts
            Recommended Articles
            Article information

            Author: Dr. Pierre Goyette

            Last Updated:

            Views: 6110

            Rating: 5 / 5 (70 voted)

            Reviews: 93% of readers found this page helpful

            Author information

            Name: Dr. Pierre Goyette

            Birthday: 1998-01-29

            Address: Apt. 611 3357 Yong Plain, West Audra, IL 70053

            Phone: +5819954278378

            Job: Construction Director

            Hobby: Embroidery, Creative writing, Shopping, Driving, Stand-up comedy, Coffee roasting, Scrapbooking

            Introduction: My name is Dr. Pierre Goyette, I am a enchanting, powerful, jolly, rich, graceful, colorful, zany person who loves writing and wants to share my knowledge and understanding with you.